207 related articles for article (PubMed ID: 37261960)
1. The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate.
Hirano M; Galarza-Muñoz G; Nagasawa C; Schott G; Wang L; Antonia AL; Jain V; Yu X; Widen SG; Briggs FBS; Gregory SG; Ko DC; Fagg WS; Bradrick S; Garcia-Blanco MA
Elife; 2023 Jun; 12():. PubMed ID: 37261960
[TBL] [Abstract][Full Text] [Related]
2. Inefficient recruitment of DDX39B impedes pre-spliceosome assembly on
Nagasawa CK; Bailey AO; Russell WK; Garcia-Blanco MA
RNA; 2024 Jun; 30(7):824-838. PubMed ID: 38575347
[TBL] [Abstract][Full Text] [Related]
3. Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.
Galarza-Muñoz G; Briggs FBS; Evsyukova I; Schott-Lerner G; Kennedy EM; Nyanhete T; Wang L; Bergamaschi L; Widen SG; Tomaras GD; Ko DC; Bradrick SS; Barcellos LF; Gregory SG; Garcia-Blanco MA
Cell; 2017 Mar; 169(1):72-84.e13. PubMed ID: 28340352
[TBL] [Abstract][Full Text] [Related]
4. Parsing the roles of DExD-box proteins DDX39A and DDX39B in alternative RNA splicing.
Banerjee S; Nagasawa CK; Widen SG; Garcia-Blanco MA
Nucleic Acids Res; 2024 May; ():. PubMed ID: 38801080
[TBL] [Abstract][Full Text] [Related]
5. DDX39B promotes translation through regulation of pre-ribosomal RNA levels.
Awasthi S; Chakrapani B; Mahesh A; Chavali PL; Chavali S; Dhayalan A
RNA Biol; 2018; 15(9):1157-1166. PubMed ID: 30176153
[TBL] [Abstract][Full Text] [Related]
6. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy.
Szymura SJ; Bernal GM; Wu L; Zhang Z; Crawley CD; Voce DJ; Campbell PA; Ranoa DE; Weichselbaum RR; Yamini B
BMC Biol; 2020 Mar; 18(1):32. PubMed ID: 32209106
[TBL] [Abstract][Full Text] [Related]
7. FOXP3 gene expression in the blood of Iranian multiple sclerosis patients.
Akbari Z; Taheri M; Jafari A; Sayad A
Hum Antibodies; 2017; 26(3):159-164. PubMed ID: 29526847
[TBL] [Abstract][Full Text] [Related]
8. The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer.
He C; Li A; Lai Q; Ding J; Yan Q; Liu S; Li Q
Cell Death Dis; 2021 Jan; 12(1):74. PubMed ID: 33436563
[TBL] [Abstract][Full Text] [Related]
9. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.
Xu Z; Li X; Li H; Nie C; Liu W; Li S; Liu Z; Wang W; Wang J
Oncogene; 2020 Nov; 39(47):7051-7062. PubMed ID: 32989256
[TBL] [Abstract][Full Text] [Related]
10. FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.
Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sørensen PS
Clin Exp Immunol; 2012 Nov; 170(2):149-55. PubMed ID: 23039885
[TBL] [Abstract][Full Text] [Related]
11. Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis.
Tarighi M; Shahbazi M; Saadat P; Daraei A; Alizadeh Khatir A; Rahimifard K; Mohammadnia-Afrouzi M
Int Immunopharmacol; 2023 Mar; 116():109797. PubMed ID: 36738680
[TBL] [Abstract][Full Text] [Related]
12. DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria.
Mendonça VR; Souza LC; Garcia GC; Magalhães BM; Lacerda MV; Andrade BB; Gonçalves MS; Barral-Netto M
Malar J; 2014 Jul; 13():278. PubMed ID: 25038626
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
14. UAP56/DDX39B is a major cotranscriptional RNA-DNA helicase that unwinds harmful R loops genome-wide.
Pérez-Calero C; Bayona-Feliu A; Xue X; Barroso SI; Muñoz S; González-Basallote VM; Sung P; Aguilera A
Genes Dev; 2020 Jul; 34(13-14):898-912. PubMed ID: 32439635
[TBL] [Abstract][Full Text] [Related]
15. Alternative Splicing of
Joly AL; Seitz C; Liu S; Kuznetsov NV; Gertow K; Westerberg LS; Paulsson-Berne G; Hansson GK; Andersson J
Circ Res; 2018 May; 122(10):1385-1394. PubMed ID: 29618596
[TBL] [Abstract][Full Text] [Related]
16. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
17. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
19. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
20. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
